Leen Kawas is a biotech executive and entrepreneur with expertise in advancing complex therapeutic programs and building investable companies. She currently serves as the CEO of EIT Pharma, where she leads a team focused on developing treatments for infectious diseases with significant unmet needs, including hepatitis D and acute respiratory infections.